Want to see NNDM full AI Analyst Report?
Top Page
Nano Dimension
(NASDAQ:NNDM)
Select Model
Select Model
Rating:54Neutral
Price Target:
$1.50
▼(-2.60% Downside)
Action:Reiterated
Date:09/06/26
Overall score is held back primarily by ongoing losses and continued negative operating/free cash flow despite improving revenue growth, partially offset by a strong low-debt balance sheet. Technicals are moderately positive with price above key short-to-mid-term moving averages and a positive MACD. Valuation remains challenged due to negative earnings, while recent M&A developments provide a modest potential catalyst but add execution risk.
Positive Factors
Accelerating Revenue Growth
Strong TTM revenue growth indicates improving customer adoption and market traction for Nano Dimension’s manufacturing solutions. If sustained, a larger revenue base can improve fixed-cost absorption, support operating leverage, and create a foundation for eventual profitability.
Negative Factors
Persistent Operating Losses
Large operating losses and deeply negative net margins show that Nano Dimension’s cost structure remains substantially ahead of its current revenue base. Continued losses could delay self-funded growth, require further capital use, and make improving revenue growth less valuable until operating leverage emerges.
Read all positive and negative factors
Positive Factors
Negative Factors
Accelerating Revenue Growth
Strong TTM revenue growth indicates improving customer adoption and market traction for Nano Dimension’s manufacturing solutions. If sustained, a larger revenue base can improve fixed-cost absorption, support operating leverage, and create a foundation for eventual profitability.
Read all positive factors
Nano Dimension (NNDM) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$341.15M
Dividend YieldN/A
Average Volume (3M)1.85M
Price to Earnings (P/E)―
Beta (1Y)1.02
Revenue Growth73.04%
EPS Growth24.91%
CountryUS
Employees468
SectorTechnology
Sector Strength88
IndustryComputer Hardware
Share Statistics
EPS (TTM)-0.76
Shares Outstanding210,839,000
10 Day Avg. Volume1,824,004
30 Day Avg. Volume1,848,285
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.60
Price to Sales (P/S)3.24
P/FCF Ratio-3.22
Enterprise Value/Market Cap>-0.01
Enterprise Value/Revenue>-0.01
Enterprise Value/Gross Profit>-0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Nano Dimension Business Overview & Revenue Model
Company Description
Nano Dimension Ltd., an Israeli enterprise operating globally through its subsidiaries, focuses on delivering additive electronics solutions. The cornerstone of its offerings is the DragonFly IV system, an advanced platform engineered to address t...
How the Company Makes Money
Nano Dimension primarily makes money through the sale of additive manufacturing equipment and the recurring and semi-recurring revenue that follows from operating that installed base. Key revenue streams typically include: (1) Hardware/system sale...
Nano Dimension Earnings Call Summary
Earnings Call Date:May 07, 2026
(Q1-2026)
| % Change Since: |
Next Earnings Date:Nov 25, 2026
Earnings Call Sentiment Neutral
The call presented a mix of clear operational progress and significant strategic transition activity: strong consolidated revenue growth (driven by the Markforged contribution), improved gross margins, meaningful liquidity and visible reductions in cash burn and stand-alone operating expenses. At the same time, the quarter included a large noncash goodwill impairment ($40.4M), a widened adjusted EBITDA loss, a year-over-year decline in stand-alone revenue, and the withdrawal of full-year guidance while the company executes complex monetization and strategic-alternative processes. The company highlighted commercial wins and continued monetization momentum but acknowledged material uncertainty and investor skepticism about certain transactions and future outcomes.Positive Updates
Consolidated Revenue Growth
Q1 revenue of $29.7 million, up approximately 106% year-over-year from $14.4 million, driven primarily by the inclusion of Markforged (Markforged contributed $17.1 million).
Negative Updates
Markforged Goodwill Impairment
The company recorded a noncash goodwill impairment of the full Markforged goodwill balance totaling $40.4 million as of quarter end, reflecting a material reduction in the carrying value of that acquisition.
Read all updates
Q1-2026 Updates
Positive
Negative
Consolidated Revenue Growth
Q1 revenue of $29.7 million, up approximately 106% year-over-year from $14.4 million, driven primarily by the inclusion of Markforged (Markforged contributed $17.1 million).
Read all positive updates
Company Guidance
Management withdrew full‑year financial guidance while it pursues strategic monetizations that could materially change results; for context Q1 revenue was $29.7M (+106% YoY from $14.4M) including $17.1M from Markforged (Nano Dimension stand‑alone revenue $12.6M, down ~12% YoY), gross profit $13.6M with adjusted gross margin ~45.9% (vs 43.3% prior year), operating expenses $26.1M (+~60% YoY; stand‑alone OpEx down ~22% YoY and >4% sequentially from $27.3M, ~20% below a ~$32.5M baseline), adjusted EBITDA loss $12.5M (vs losses of $10.1M YoY and $9.8M sequentially), cash and equivalents plus deposits and marketable securities ~$441.6M (down ~$18M from $459.6M, including an $8.4M fair‑value change and about $9.6M from lower operating cash burn), the AME/Fabrica sale closed April 6 (expected to reduce annualized cash burn by ~ $10M), and a $40.4M non‑cash goodwill impairment related to Markforged was recorded — all cited as reasons to pause guidance until monetizations and strategic options are finalized.Nano Dimension Financial Statement Overview
Summary
Income Statement
28
Negative
Balance Sheet
74
Positive
Cash Flow
32
Negative
| Breakdown | TTM | Mar 2026 | Mar 2025 | Dec 2023 | Dec 2022 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 120.89M | 102.44M | 57.77M | 56.31M | 43.63M | 10.49M |
| Gross Profit | 46.88M | 34.34M | 24.89M | 26.06M | 14.05M | 1.12M |
| EBITDA | -128.57M | -86.99M | -96.15M | -54.67M | -220.57M | -198.11M |
| Net Income | -163.41M | -293.30M | -98.83M | -55.97M | -227.42M | -200.78M |
Balance Sheet | ||||||
| Total Assets | 556.77M | 638.22M | 901.89M | 1.06B | 1.20B | 1.39B |
| Cash, Cash Equivalents and Short-Term Investments | 432.10M | 457.82M | 757.96M | 851.54M | 1.03B | 1.29B |
| Total Debt | 19.80M | 9.24M | 10.79M | 13.81M | 17.96M | 6.53M |
| Total Liabilities | 75.28M | 86.24M | 43.18M | 48.55M | 53.17M | 45.72M |
| Stockholders Equity | 481.49M | 551.99M | 857.99M | 1.01B | 1.15B | 1.34B |
Cash Flow | ||||||
| Free Cash Flow | -66.86M | -103.16M | -59.92M | -115.69M | -101.44M | -468.36M |
| Operating Cash Flow | -66.04M | -102.09M | -57.01M | -105.07M | -92.05M | -42.58M |
| Investing Cash Flow | 248.85M | 969.63K | 140.05M | -166.60M | -67.67M | -496.68M |
| Financing Cash Flow | -25.17M | -15.11M | -74.45M | -105.41M | -5.27M | 804.18M |
Nano Dimension Technical Analysis
Positive
1.54
Price Trends
1.53
Positive
1.58
Positive
1.68
Negative
Market Momentum
0.01
Negative
60.25
Neutral
74.44
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NNDM, the sentiment is Positive. The current price of 1.54 is below the 20-day moving average (MA) of 1.58, above the 50-day MA of 1.53, and below the 200-day MA of 1.68, indicating a neutral trend. The MACD of 0.01 indicates Negative momentum. The RSI at 60.25 is Neutral, neither overbought nor oversold. The STOCH value of 74.44 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NNDM.
Nano Dimension Risk Analysis
Nano Dimension disclosed 40 risk factors in its most recent earnings report. Nano Dimension reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Nano Dimension Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | $974.61M | -1.87 | 167.40% | ― | 10.90% | 35.72% | |
54 Neutral | $341.15M | -2.13 | -30.81% | ― | 73.04% | 24.91% | |
53 Neutral | $574.87M | -8.52 | -22.63% | ― | -6.22% | 61.98% | |
53 Neutral | $248.70M | 89.02 | 3.29% | ― | -12.77% | ― | |
49 Neutral | $700.70M | -5.97 | -13.79% | ― | -3.05% | -0.01% | |
37 Underperform | $260.03M | -1.04 | -55.85% | 3.74% | 61.11% | 66.24% |
* Technology Sector Average
NNDM
Nano Dimension
1.62
0.18
12.50%
DDD
3D Systems
3.46
1.29
59.45%
QMCO
Quantum
24.73
17.14
225.82%
SSYS
Stratasys
8.00
-2.30
-22.33%
OSS
One Stop Systems
9.97
4.40
78.99%
CAN
Canaan
0.36
-0.34
-48.72%
Nano Dimension Corporate Events
Business Operations and StrategyExecutive/Board Changes
Nano Dimension Adds Independent Director to Board and Committees
Neutral
Aug 18, 2026
On August 16, 2026, Nano Dimension Ltd. appointed Nadav Kidron as a Class II independent director, effective immediately, with his term running until the 2026 annual shareholders’ meeting. Kidron, a seasoned executive who leads Oramed Pharma...
Business Operations and StrategyExecutive/Board ChangesShareholder Meetings
Nano Dimension Overhauls Board, Appoints Interim CEO
Neutral
Jul 21, 2026
Nano Dimension has reached a settlement agreement with major shareholder Murchinson that reshapes its governance and cancels a contentious Extraordinary General Meeting previously scheduled for July 31, 2026. The July 17, 2026 agreement led to the...
Business Operations and StrategyM&A Transactions
Nano Dimension Details Infinite Epigenetics Business Combination Plans
Positive
Jun 17, 2026
On June 16, 2026, Nano Dimension and Infinite Epigenetics released additional information on their proposed business combination, emphasizing Infinite’s status as an operating diagnostics platform with established epigenetic science, a sizab...
Business Operations and StrategyM&A Transactions
Nano Dimension Signs Term Sheet for Infinite Epigenetics Merger
Positive
Jun 15, 2026
On June 15, 2026, Nano Dimension Ltd. entered into a non-binding term sheet with Infinite Epigenetics, Inc. outlining a proposed business combination in which Nano, or a successor public company, would acquire all of Infinite’s equity in an ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.